~~<i id='D526052163'><strike id='D526052163'><tt id='D526052163'><pre id='D526052163'></pre></tt></strike></i>~~

Home» explore» comprehensive

comprehensive

author：focus 2025-09-27 09:19:30 Page View：64

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Sanders wants to replace patents with prizes for drug inventions
Next article： United colonoscopy coverage change 'may cost lives,' doctors say

explore

Supreme Court strikes down use of affirmative action

ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

There’s a way to spot data fakery. All journals should be using it

STAT,APStockAstheBritishpoliticianBenjaminDisraelifamouslyobserved,therearelies,damnlies,andstatisti

George Santos makes 1st court appearance after pleading not guilty to 13 counts

1:57GeorgeSantosarrivesatfederalcourtJune30,2023,inCentralIslip,N.Y.JohnMinchillo/APRep.GeorgeSantos

Citing H5N1 threat, CDC urges peak flu monitoring this summer

ANGELAWEISS/AFPviaGettyImagesTheCentersforDiseaseControlandPreventionaskedlocalandstatehealthofficia